Cargando…
A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol
INTRODUCTION: Pre-eclampsia is a major complication of pregnancy, globally responsible for 60 000 maternal deaths per year, and far more fetal losses. There is no definitive treatment other than delivery. A therapeutic that could quench the disease process would be useful to treat preterm pre-eclamp...
Autores principales: | Cluver, Catherine, Walker, Susan P, Mol, Ben W, Hall, David, Hiscock, Richard, Brownfoot, Fiona C, Kaitu’u-Lino, Tu’uhevaha J, Tong, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503454/ https://www.ncbi.nlm.nih.gov/pubmed/31023758 http://dx.doi.org/10.1136/bmjopen-2018-025809 |
Ejemplares similares
-
Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial
por: Cluver, Catherine A, et al.
Publicado: (2021) -
Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol
por: Cluver, Catherine A, et al.
Publicado: (2015) -
Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
por: Hastie, Roxanne, et al.
Publicado: (2022) -
Therapeutic interventions: The importance of including diseased and healthy samples in preclinical studies
por: Tu'uhevaha J., Kaitu'u-Lino
Publicado: (2019) -
Measuring circulating miRNAs in early pregnancy could identify fetuses’ destined to undergrow and be at increased risk of stillbirth
por: Tong, Stephen, et al.
Publicado: (2020)